• UK researchers develop compound to kill superbugs pharmaceutical-technology
    May 30, 2019
    Research teams from the University of Sheffield and Rutherford Appleton Laboratory (RAL) in the UK have developed a compound that could kill antibiotic-resistant superbugs.
  • Schrödinger raises $110m to develop drug discovery platform pharmaceutical-technology
    May 22, 2019
    Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
  • BM32 vaccine developed against rhinitis europeanpharmaceuticalreview
    April 30, 2019
    Researchers have shown that the synthetically manufactured vaccine BM32 relieves the symptoms of rhinitis…
  • Researchers develop new treatment for TB pharmaceutical-technology
    January 10, 2019
    A team of researchers has developed a novel treatment for tuberculosis (TB), which has the potential to be ‘scaled-up’ for clinical testing.
  • Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
    November 26, 2018
    A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
PharmaSources Customer Service